This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Millennium Pharmaceuticals Limited. Active years: 2005-2017.
Company Filing History:
Years Active: 2005-2017
Title: Benjamin Stone Amidon: Innovator in Chemical Entities
Introduction
Benjamin Stone Amidon is a notable inventor based in Arlington, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of chemical entities that target specific disorders. With a total of 2 patents, his work has implications for treating serious health conditions.
Latest Patents
Amidon's latest patents include innovative compounds designed to inhibit Uba6, which are crucial for addressing cell proliferation disorders, including various cancers. The first patent discloses chemical entities that inhibit Uba6, detailing compounds of specific formulas and their pharmaceutical applications. The second patent focuses on a yeast cell model that incorporates mammalian proteins to identify potential anti-proliferative agents, showcasing a novel approach to drug discovery.
Career Highlights
Amidon is currently associated with Millennium Pharmaceuticals Limited, where he continues to advance his research in pharmaceutical sciences. His work is characterized by a commitment to developing effective treatments for complex diseases.
Collaborations
Throughout his career, Amidon has collaborated with esteemed colleagues such as Paul D. Greenspan and David P. Cardin. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Benjamin Stone Amidon exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborative efforts are paving the way for advancements in medical treatments.